MedTrace Logo

Enhanced Screening for Early Treatment Targets After MTBI

NCT03221218 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-03-02

No results posted yet for this study

Summary

The study will examine whether enhancing screening-informed follow-up letters will improve (i) family physician compliance with best practice guidelines for managing persistent symptoms following concussion, and (ii) clinical outcomes from concussion.

Conditions

  • Brain Concussion

Interventions

OTHER

Enhanced screening-informed follow up letter

Family Physicians will be sent a letter that includes their screening test results and associated symptom-specific recommendations from the Ontario Neurotrauma Foundation clinical practice guidelines.

Sponsors & Collaborators

  • Vancouver Coastal Health

    collaborator OTHER_GOV

  • Fraser Health

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Noah Silverberg, PhD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-09
Primary Completion
2019-10-30
Completion
2021-06-22

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03221218 on ClinicalTrials.gov